These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10081332)

  • 41. The three dimensions of managed care pharmacy practice.
    Gouveia WA; Shane R
    Am J Manag Care; 1997 Feb; 3(2):231-9. PubMed ID: 10169257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Drug Formulary Committee in a developing country.
    Fraser HS; Prescod L
    Hosp Formul; 1986 Sep; 21(9):957-9. PubMed ID: 10278614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of formularies on clinical innovation.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 17():11-4. PubMed ID: 14680421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.
    International Liaison Committee on Resuscitation
    Pediatrics; 2006 May; 117(5):e955-77. PubMed ID: 16618790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of guidelines for palliative care pharmacotherapy.
    Weschules DJ
    J Pain Palliat Care Pharmacother; 2005; 19(4):25-38. PubMed ID: 16431830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of the drug formulary in a valve-based pharmacy benefit.
    Giaquinta D
    Manag Care Interface; 2005 Aug; 18(8):37-8. PubMed ID: 16127890
    [No Abstract]   [Full Text] [Related]  

  • 48. Do P&T committees have enough power? Plans and PBMs are divided about sharing drug prices with clinicians. Is it better to have an administrative committee determine the formulary?
    Cross M
    Manag Care; 2007 Apr; 16(4):39-42. PubMed ID: 17491288
    [No Abstract]   [Full Text] [Related]  

  • 49. Legislative challenges facing managed care pharmacy.
    Epstein L
    Manag Care Interface; 1997 Oct; 10(10):92-4, 98. PubMed ID: 10174422
    [No Abstract]   [Full Text] [Related]  

  • 50. Managed care guidelines for the economic evaluation of pharmaceuticals.
    Langley PC; Martin RE
    Am J Manag Care; 1997 Jul; 3(7):1013-21. PubMed ID: 10173366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding, creating, and working with formulary systems.
    Quinn CE; Barisano A
    Am J Manag Care; 1999 Oct; 5(10):1311-7; quiz 1318-9. PubMed ID: 10622996
    [No Abstract]   [Full Text] [Related]  

  • 52. Impact of clinician judgement on formulary committees' recommendations in Canada.
    Oremus M; Raina P; Eva K; Lavis J; Nair K; Lo A; Smith S
    J Health Serv Res Policy; 2010 Apr; 15(2):98-105. PubMed ID: 20147424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Formulary revision: eliciting the opinions of users.
    McGavock H; Wilson-Davis K; McGavock SA
    Br J Gen Pract; 1996 Jul; 46(408):419-21. PubMed ID: 8776914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A public-health approach to site-specific formulary management: addressing deficient drug supplies in Malawi.
    Lauffenburger JC; Jonkman LJ; Lange CE; Connor SE; Sibale C
    Int J Pharm Pract; 2011 Jun; 19(3):201-5. PubMed ID: 21554446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reflections on the Formulary System from 1997 to the Present.
    Avey SG
    J Manag Care Spec Pharm; 2020 Apr; 26(4):350-351. PubMed ID: 32223598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AMCP Partnership Forum: Principles for Sound Pharmacy and Therapeutics (P&T) Committee Practices: What's Next?
    J Manag Care Spec Pharm; 2020 Jan; 26(1):48-53. PubMed ID: 31880220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formulary decisions: then and now.
    Boucher BA
    Pharmacotherapy; 2010 Jun; 30(6 Pt 2):35S-41S. PubMed ID: 20500042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implementation of an outpatient prescription drug formulary in a managed-care system.
    Black J; Griffin T; Beisel NW; Bartels MD
    Am J Hosp Pharm; 1988 Mar; 45(3):561-5. PubMed ID: 3130754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of patient notification of formulary change on formulary adherence.
    Delate T; Henderson R
    J Manag Care Pharm; 2005; 11(6):493-8. PubMed ID: 15998166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug formularies--good or evil? A view from a managed care provider.
    Giaquinta D
    Cardiology; 1994; 85 Suppl 1():30-5. PubMed ID: 7743532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.